With winter approaching, it's important to protect infants from RSV, which is very harmful to the very young. A safe and effective vaccine is available for pregnant women and newborns. Learn more: Le rle des vaccins et des anticorps monoclonaux dans l'immunisation Sanofi Monoclonal Antibody Prophylaxis for Infectious Diseases Mabion Le 18 septembre, l'Agence europenne du mdicament (EMA) a donn son feu vert la commercialisation d'Enflonsia (clesrovimab, MSD), un nouvel anticorps monoclonal destin la prvention des infections des voies respiratoires Maternal #RSV vaccination and nirsevimab reduced RSV associated hospitalizations among US infants in 20242025 by up to 51%. Both interventions demonstrated high effectiveness and durability in real world surveillance. https: ja.ma 4saoasz COVID 19 and Vaccines and mABs, Oh My! NephJC